We present a computational manufacturing program for monitoring group delay dispersion (GDD). Two kinds of dispersive mirrors computational manufactured by GDD, broadband, and time monitoring simulator are compared. The results revealed the particular advantages of GDD monitoring in dispersive mirror deposition simulations. The self-compensation effect of GDD monitoring is discussed. GDD monitoring can improve the precision of layer termination techniques, it may become a possible approach to manufacture other optical coatings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1364/OE.483887 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The synergic impacts of air pollution control policies on pollutants and carbon emissions.
J Environ Manage
November 2024
Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China.
The Chinese government implemented air pollution control policies in its Five-Year Plans (FYPs), setting specific emission reduction targets for different regions. This study employed the generalized difference-in-differences (GDD) method to assess the impacts of air pollution control policies on pollutants and carbon emissions from 2003 to 2020. This study had three main findings.
View Article and Find Full Text PDFDe-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
Lancet
September 2024
Division of Cardiology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Electronic address:
Background: Dual antiplatelet therapy (DAPT) for 12 months is the standard of care after coronary stenting in patients with acute coronary syndrome (ACS). The aim of this individual patient-level meta-analysis was to summarise the evidence comparing DAPT de-escalation to ticagrelor monotherapy versus continuing DAPT for 12 months after coronary drug-eluting stent implantation.
Methods: A systematic review and individual patient data (IPD)-level meta-analysis of randomised trials with centrally adjudicated endpoints was performed to evaluate the comparative efficacy and safety of ticagrelor monotherapy (90 mg twice a day) after short-term DAPT (from 2 weeks to 3 months) versus 12-month DAPT in patients undergoing percutaneous coronary intervention with a coronary drug-eluting stent.
Regional differences in the impact paths of climate on aboveground biomass in alpine grasslands across the Qinghai-Tibet Plateau.
Sci Total Environ
October 2024
State Key Laboratory of Remote Sensing Science, Beijing Normal University, Beijing 100875, China; Beijing Engineering Research Center for Global Land Remote Sensing Products, Faculty of Geographical Science, Beijing Normal University, Beijing 100875, China.
Alpine grasslands on the Qinghai-Tibet Plateau (QTP) play an essential role in water conservation, biodiversity protection and climate feedback, with aboveground biomass (AGB) serving as a crucial indicator of grassland health and functionality. While previous studies have independently explored the phenological differences, cumulative effects, and spatial variability of climatic impacts on biomass/productivity in alpine grasslands, the cascading effects regarding climate and phenology on AGB still present knowledge gaps. Here, using peak AGB measurements, remote sensing and gridded climate data in the QTP alpine grasslands during 2002-2018, we systematically analyzed the impact paths of climatic variables (i.
View Article and Find Full Text PDFImpact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel.
J Hematol Oncol
June 2024
Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Idecabtagene vicleucel (Ide-cel) has demonstrated excellent efficacy and durable responses in patients with relapsed/refractory multiple myeloma (RRMM). However, the outcomes with ide-cel in patients with extramedullary disease (EMD) remain incompletely characterized. We included patients with RRMM treated with ide-cel between May 2021 and April 2023 across 11 US academic institutions.
View Article and Find Full Text PDFCenobamate Plasma Levels in Patients with Epilepsy: Correlation with Efficacy and Tolerability?
J Clin Med
May 2024
Kork Epilepsy Center, Kehl-Kork, 77694 Kehl, Germany.
Cenobamate is approved by the European Medicine Agency for the treatment of adult patients with epilepsy (PWEs) with ongoing focal-onset seizures despite appropriate treatment with at least two established antiseizure medications. Pivotal trials and post-marketing real-world observational studies suggest high efficacy with unusually high seizure-free rates. The authors sought to investigate the plasma levels of cenobamate under steady-state conditions in seizure-free versus non-responding PWEs, and in PWEs who experienced adverse events versus those who did not.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!